Alexander Harris, MD
Radiation Oncology · Hoffman Estates, ILNPI 1700236635
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,505 of the $2,030 with a category attached, or 74.1%. 17 manufacturers reported payments, led by AstraZeneca at 28.4% of the total.
Across 40 payments — averaging $50.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$577
- Teleflex LLC$303
- Boston Scientific$200
- Bayer$172
- Novocure Inc.$142
- Varian Medical Systems, Inc.$134
- plus $501 from 11 others
What the payments were for
- Consulting fees$52526%
- Food & beverage$1,50574%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $577 |
| Teleflex LLC | 4 | $303 |
| Boston Scientific | 6 | $200 |
| Bayer | 4 | $172 |
| Novocure Inc. | 1 | $142 |
| Varian Medical Systems, Inc. | 1 | $134 |
| Merck | 5 | $108 |
| Novartis | 4 | $102 |
| Blue Earth Diagnostics | 3 | $75 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Penumbra, Inc. | 1 | $34 |
| Cardinal Health 414 LLC | 1 | $29 |
| Tactile Systems Technology Inc | 1 | $26 |
| Sirtex Medical Inc | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$525
- Optune Gio$285
- Barrigel$219
- Xofigo$114
How this compares
$2,030 in reported general payments places this provider in the 80th percentile of 242 radiation oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 47 | $545 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $273 |
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $136 |
| Ondansetron Hcl | 13 | $44 |
| Lorazepam | 15 | $16 |
| Ciprofloxacin Hcl | 13 | $16 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Hoffman Estates
- Ramji RajendranElk Grove Village$207K
- Brian BaumannSpringfield$204K
- Tamer RefaatFreeport$151K
- Parthiv MehtaGlenview$149K
- Sean PitrodaChicago$103K
- Aditya JulooriChicago$73K
- Steven ChmuraChicago$59K
- Marc PosnerLake Forest$55K
- William SmallChicago$54K
- Ken TatebeChicago$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.